Convergence science centre accelerates development of innovative cancer therapies
Tumour-promoting pink and tumour-suppressing blue immune cells being tracked using newly developed technology. Courtesy: Masahiro Ono The new £ million Cancer Research UK Convergence Science Centre at The Institute of Cancer Research ICR and Imperial College London brings together researchers from different scientific disciplines to develop a range of innovative cancer treatment techniques. Under the leadership of cancer experts Paul Workman from the ICR and Lord Ara Darzi from Imperial, the centre integrates knowledge, methods and expertise from disciplines ranging…